preCharge News BUSINESS — Prosecutors announced on Tuesday that Gilead Sciences agreed to pay $202 million to settle claims it “unlawfully” used speaker programs to funnel kickbacks to doctors to induce them to prescribe the pharmaceutical company’s medications to patients with HIV.
“Gilead spent tens of millions of dollars on these programs, including over $20 million in speaking fees and millions more in exorbitant meals, alcohol and travel, all in an effort to induce doctors to prescribe Gilead’s HIV drugs and drive up sales,” interim Manhattan U.S. Attorney Jay Clayton said in a statement.
Gilead will pay the settlement to the U.S. government and various states. The stock was last trading unchanged on the day.
Want to earn some extra money on the side? Buy PCPi Coin or Subscribe to VIP and get dividens monthly.
____
Associated Press, CNBC News, Fox News, and preCharge News contributed to this report.
























